Skip to NavigationSkip to content


Sanofi's Dr Eckhard Leifke joins Seattle-based biotech Omeros

Published on: 06/08/18

The Seattle-based biotech Omeros have announced that Sanofi’s Dr Eckhard Leifke will join the commercial-stage biopharmaceutical company as Chief Medical Officer and Vice President of Clinical Development, a position which he will take over from previous Vice President of Clinical Development Dr J Steven Whitaker.

Dr Leifke is set to oversee medical affairs, pharmacovigilance, clinical science and operations as he aims to focus on driving the clinical aspects of Omeros’ MASP-2 antibody – OMS721 towards US and international regulatory approval.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches